| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Goat |
| Applications | ELISA,WB-Ti,IHC-P |
| Brand: | Abnova |
| Reference: | PAB6144 |
| Product name: | CREB3L4 polyclonal antibody |
| Product description: | Goat polyclonal antibody raised against synthetic peptide of CREB3L4. |
| Gene id: | 148327 |
| Gene name: | CREB3L4 |
| Gene alias: | AIBZIP|ATCE1|CREB3|CREB4|JAL|hJAL |
| Gene description: | cAMP responsive element binding protein 3-like 4 |
| Immunogen: | A synthetic peptide corresponding to human CREB3L4. |
| Immunogen sequence/protein sequence: | C-PSGRIRSVLHADEM |
| Protein accession: | NP_570968 |
| Form: | Liquid |
| Concentration: | 0.5 mg/mL |
| Recommend dilutions: | ELISA (1:32000) Western blot (0.5-2 ug/mL) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (2-4 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Goat |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: | ![]() |
| Application image note: | CREB3L4 polyclonal antibody (Cat # PAB6144) staining (0.5 ug/mL) of human placenta lysate (RIPA buffer, 35 ug total protein per lane). Primary incubated for 1 hour. Detected by western blot using chemiluminescence. |
| Applications: | ELISA,WB-Ti,IHC-P |
| Shipping condition: | Dry Ice |
| Publications: | AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells.Qi H, Fillion C, Labrie Y, Grenier J, Fournier A, Berger L, El-Alfy M, Labrie C. Cancer Res. 2002 Feb 1;62(3):721-33. |